Experimental peptide targets Covid-19
The research described in this article has been published on a preprint server but has not yet been peer-reviewed by scientific or medical experts. Using computational models of protein interactions, researchers at the MIT Media Lab and Center for Bits and Atoms have designed a peptide that can bind to coronavirus proteins and shuttle them into a cellular pathway that breaks them down. This type of peptide could hold potential as a treatment that would prevent the SARS-CoV-2 virus...